The corporate coauthor
- PMID: 15987332
- PMCID: PMC1490131
- DOI: 10.1111/j.1525-1497.2005.05857.x
The corporate coauthor
Abstract
Drug marketing techniques include the sponsorship of articles signed by academic physicians or researchers and submitted to peer-reviewed medical journals. Some of these articles are authored or coauthored by ghostwriters who work for pharmaceutical companies or medical education companies hired by pharmaceutical companies. Conflicts of interest may be difficult to detect in the subset of articles and presentations sponsored by pharmaceutical companies that never mention the targeted drug, but focus on stimulating the perceived need for the targeted drug or highlighting problems with competing drugs. The current voluntary standards for declaring conflicts of interest to readers of medical journals and audiences at medical conferences are inadequate. A public database that contains conflicts of interest of physicians and researchers would be useful.
Comment in
-
Scientific discourse, corporate ghostwriting, journal policy, and public trust.J Gen Intern Med. 2005 Jun;20(6):550-1. doi: 10.1111/j.1525-1497.2005.41008.x. J Gen Intern Med. 2005. PMID: 15987334 Free PMC article. No abstract available.
-
Response to "the corporate coauthor".J Gen Intern Med. 2005 Jul;20(7):672. doi: 10.1111/j.1525-1497.2005.051181.x. J Gen Intern Med. 2005. PMID: 16050869 Free PMC article. No abstract available.
-
Comments on "The corporate author".J Gen Intern Med. 2005 Oct;20(10):972; author reply 972-3. doi: 10.1111/j.1525-1497.2005.051391_1.x. J Gen Intern Med. 2005. PMID: 16191155 Free PMC article. No abstract available.
-
The corporate co-author, the ghostwriter, and the medical society: an object lesson (June, 2005 issue).J Gen Intern Med. 2006 Jan;21(1):102. doi: 10.1111/j.1525-1497.2005.00271_3.x. J Gen Intern Med. 2006. PMID: 16423136 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources